## What Is Looksmaxxing and Why Are Young Men Obsessed With It?

A quietly growing movement is reshaping how young men think about their appearance — and some are willing to go to extraordinary lengths to achieve what they consider the ideal face and body.

Take Marvin, a 26-year-old who rates his own attractiveness at a "solid 7 out of 10." He believes a sharper jawline and clearer skin could push him closer to a 9. For Marvin, this isn't wishful thinking — it's a structured daily mission.

His mornings begin before sunrise with an intense gym session. Once home, the real regimen kicks in: alternating warm and freezing cold showers, a thorough face cleanse, and rubbing a frozen cucumber across his skin to reduce puffiness and boost his complexion. He then moves through a series of targeted facial exercises, which he regularly shares with his 35,000 TikTok followers.

### The Exercises Behind the Obsession

Marvin demonstrates two of his go-to techniques. The first, called the "Zygopush," involves pressing his thumbs firmly beneath his cheekbones and massaging upward toward his ears — a move he claims hollows out the cheeks. The second, the "Hunter squeeze," has him pressing his index fingers against his temples while squinting his eyes, with the goal of creating a sharper, more angular eye shape.

He laughs as he walks through the routine. "People do sometimes think, 'What is this man doing?'" he admits. Yet he remains firmly convinced it's working. He describes the goal as a chiselled, hollow-cheeked profile with a strong jawline and intense eyes — the moment a man truly "peaks." He credits this pursuit with transforming him from a dissatisfied tradesman into a self-made online entrepreneur.

## Softmaxxing vs. Hardmaxxing: Understanding the Spectrum

This is the world of **looksmaxxing** — a rapidly expanding online subculture in which young men pursue physical perfection as a pathway to a better life overall.

The practice spans a wide range of approaches. On the gentler end sits **softmaxxing**: regular gym workouts, structured skincare routines, improved sleep habits, and dietary changes. Further along the spectrum lies **hardmaxxing**, which can involve taking unregulated peptides, growth hormones, or even undergoing jaw surgery to achieve a more angular, prehistoric-looking facial structure.

Some practitioners go even further, engaging in so-called "bone smashing" — deliberately striking the jawbone to supposedly reshape it over time. This, along with hormone use without medical supervision, is firmly discouraged by health professionals.

For those who don't engage with looksmaxxing at all, Marvin warns of falling into the "sub three" category — his term for someone who isn't particularly attractive and isn't trying to change that.

Face-rating apps, which analyze uploaded photos and suggest areas for improvement, have become a popular tool within the community. Many such apps carry thousands of user reviews across major app stores.

## The Influencers Driving the Movement

Among the most prominent figures in looksmaxxing is Braden Peters, who goes by the online handle "Clavicular." The 20-year-old is considered a "giga chad" within the community — a perfect 10 — and says he "mogs" everyone around him, meaning his presence simply outshines others.

Peters attributes his appearance to several controversial practices, including taking testosterone from the age of 14 and using a hammer to physically reshape his jaw. Neither approach carries any medical endorsement. Despite the controversy, his content — alongside that of similar creators — has helped push looksmaxxing from obscure internet forums into mainstream social media feeds.

## A Gateway to the Manosphere?

Not everyone views looksmaxxing as harmless self-improvement. Researchers and journalists who study the **manosphere** — an ultra-masculine online subculture that recently featured in a Louis Theroux documentary — argue that looksmaxxing can serve as an entry point into far more troubling ideological territory.

The term itself has roots in **incel forums**: online communities of men who identify as "involuntarily celibate" and often promote deeply misogynistic views, blaming women for their own romantic and sexual failures.

Investigative journalist Matt Shea, who has reported extensively on toxic masculinity and previously interviewed influencer Andrew Tate, sees a common thread running through looksmaxxing culture and more extreme male influencer content.

"They tell young men how worthless they are," Shea explains, "then offer themselves up as the solution."

The business model, he says, revolves around selling courses designed to boost a man's "sexual market value" (SMV) — essentially a numerical score of physical attractiveness. The higher the SMV, the theory goes, the greater the chances of romantic or sexual success. If that still doesn't work, the ideology conveniently shifts the blame onto women.

"That," Shea warns, "is when it becomes dangerous."

## Not All Looksmaxxers Are the Same

A scroll through looksmaxxing content online quickly reveals that the community is far from monolithic. Many participants actively distance themselves from incel ideology and misogynistic messaging.

Leander is one such example. He agreed to speak on the condition that he not be associated with incel culture in any way. Like Marvin, he identifies as a softmaxxer — someone focused on self-improvement for personal confidence rather than ideological reasons.

Following a breakup in 2023, Leander began exploring looksmaxxing content and built his own daily routine. He trains at the gym five times a week, takes regular ice-cold face baths to reduce puffiness, makes a conscious effort to sleep on his back, and has eliminated pornography from his life — something he believes distorts how men perceive and relate to women.

Unlike Marvin, Leander doesn't assign himself a numerical score. He simply says he feels good about his appearance around 80% of the time. He is, however, candid about the limits of softmaxxing: without a naturally conventional appearance as a baseline, he believes there is only so much these routines can achieve.

## The Bigger Picture

Looksmaxxing reflects something much broader than vanity — it taps into deep-seated anxieties about masculinity, self-worth, and social status that many young men are navigating in an increasingly image-driven world. Whether a personal wellness project or a rabbit hole leading somewhere far darker, its influence on a generation of young men is impossible to ignore.

Young men are obsessing over jaw surgery, facial exercises, and face-rating apps in pursuit of perfection. Inside the growing world of looksmaxxing.

Looksmaxxing Explained: The Male Beauty Trend Raising Concer

23d953e0-1fd0-11f1-801d-ed3cff6bf876.jpg

The Looksmaxxing Phenomenon: How Young Men Are Obsessing Over the Perfect Face

## From Breakthrough Sensation to Bench Warmer

Less than twelve months ago, Myles Lewis-Skelly was turning heads across Europe, producing a standout performance for Arsenal in a Champions League quarter-final against Real Madrid. The teenager looked destined to become England's first-choice left-back heading into the next World Cup. Fast forward to today, and the 19-year-old finds himself battling to stay relevant in Mikel Arteta's increasingly competitive squad.

So what exactly has changed — and where does his future lie?

## A Breakout Season That Raised Expectations

Lewis-Skelly's rise during the 2024-25 campaign was nothing short of remarkable. With Arsenal hit hard by injuries across their backside options, the academy graduate stepped up and seized his opportunity, eventually earning a well-deserved five-year contract extension over the summer.

His impressive club form translated directly onto the international stage. In March of last year, Lewis-Skelly etched his name into the history books by becoming the youngest player ever to score on his England debut, netting the opening goal in a comfortable 2-0 victory over Albania at Wembley. He went on to start four World Cup qualifying fixtures and featured in four of Thomas Tuchel's first five England squads — before a lack of regular club minutes saw him dropped from the November camp.

## Arsenal's 'Win Now' Mentality Squeezes Out Youth

The core issue for Lewis-Skelly is straightforward: Arsenal are no longer in rebuilding mode. After three consecutive Premier League runner-up finishes, Arteta is under immense pressure to finally deliver the title — the club's first since 2004. That urgency has dramatically shifted the club's transfer strategy.

Rather than nurturing talent for the future, Arsenal have invested heavily in proven, physically dominant players in their prime. Riccardo Calafiori, signed for £42 million in 2024, and Piero Hincapie, brought in on loan from Bayer Leverkusen with a purchase option worth approximately £45 million, now occupy the left-back positions ahead of Lewis-Skelly. High-profile additions such as Viktor Gyokeres, Martin Zubimendi, and Eberechi Eze further underline Arsenal's intent to win immediately.

Hincapie, in particular, represents a significant obstacle. The Ecuador international was a cornerstone of the Leverkusen side that completed an unbeaten Bundesliga season in 2024-25 and won the German Cup the season prior. His physical intensity and defensive aggression align perfectly with Arteta's demands — and new backroom addition Gabriel Heinze is reportedly a major admirer of the defender as well.

### Fellow Academy Product Already Sent on Loan

The situation echoes the fate of another Arsenal youth product. Ethan Nwaneri, unable to secure consistent first-team minutes, was shipped out on loan to Marseille. The message is becoming clearer — even elite academy graduates are not immune to being sidelined when the club's ambitions require experienced personnel.

## The Numbers Behind His Season

Last season, Lewis-Skelly started 26 of Arsenal's 42 matches, largely due to injury absences affecting Calafiori, Oleksandr Zinchenko, and Kieran Tierney. This season tells a very different story. He has appeared in 26 games but started only 12, with just a single Premier League start to his name.

That said, his Champions League record this term offers genuine encouragement. Lewis-Skelly has started six of Arsenal's nine European fixtures, including memorable victories over Bayern Munich and Atletico Madrid — where he produced an eye-catching forward run and a key assist — as well as a full 90-minute showing during Arsenal's win over Inter Milan at the San Siro.

## Arteta Backs Lewis-Skelly Despite Limited Role

When pressed on the youngster's reduced involvement, Arteta remained measured and supportive.

"Every season is different," the Arsenal manager explained. "He had very good moments this season. He had other moments when he hasn't played that much. Sometimes it's the good form of your team-mates. There are a lot of factors. But he's doing well."

Arteta has demonstrated a willingness to blood young talent — six new debutants have been handed their first-team bows this season — but there remains a clear distinction between a cameo introduction and earning a spot in high-stakes fixtures.

## A Changing Role That Doesn't Suit His Strengths

Beyond simple competition for places, there is a tactical dimension to Lewis-Skelly's reduced role. His greatest asset has been his ability to invert into midfield when Arsenal build from the back, combining positional intelligence with technical quality. However, Arteta's evolved system this season places different demands on the full-back position, making those specific qualities less central to the team's structure.

## What Does the Summer Hold?

Lewis-Skelly's situation presents an intriguing dilemma heading into the off-season. With World Cup selection looking increasingly out of reach if his game time doesn't improve significantly, serious conversations about his immediate career path seem inevitable.

It is also worth noting that, having come through the academy, Lewis-Skelly would represent pure profit on Arsenal's financial books — a factor that could make him an attractive selling asset if the right offer emerged.

On the positive side, he has still accumulated enough Premier League appearances to potentially receive a title winner's medal should Arsenal go all the way in May. And at just 19 years old, with a Champions League pedigree and an England debut already behind him, very few players his age can claim comparable achievements.

The challenge for Lewis-Skelly now is ensuring that the extraordinary start to his career becomes a foundation — not a peak.

Myles Lewis-Skelly went from Champions League hero to Arsenal squad player in under a year. Here's what happened and what comes next for the teenager.

Myles Lewis-Skelly: Arsenal's Forgotten Teenage Star

0d504bc0-1ec6-11f1-82a8-07e825302dba.jpg

Myles Lewis-Skelly: From Champions League Star to Arsenal Fringe Player

## This Week's Most Fascinating Science Stories

From the relationship between physical activity and cognitive health to surprising discoveries about hedgehog hearing, science continues to deliver remarkable insights. The Guardian's science editor Ian Sample sat down with Madeleine Finlay to break down three of the most compelling research stories making headlines this week.

## Exercise and Its Impact on Brain Function

One of the week's standout studies delves into the connection between regular physical activity and brain health. Researchers have been examining how exercise influences cognitive performance and overall neurological well-being. The findings add to a growing body of evidence suggesting that staying physically active isn't just good for the body — it plays a critical role in maintaining and even enhancing how the brain operates. This research has significant implications for public health strategies aimed at reducing cognitive decline.

## Hedgehogs Can Hear Ultrasound — And It Could Save Their Lives

In a surprising zoological breakthrough, scientists have discovered that hedgehogs possess the ability to detect high-frequency ultrasound. This finding opens up exciting possibilities for wildlife conservation, particularly when it comes to protecting these small mammals from road traffic — one of the leading causes of hedgehog fatalities.

### Using Sound to Protect Wildlife

Researchers are now exploring whether ultrasound repeller devices could be strategically deployed near roads to deter hedgehogs from venturing into dangerous areas. If effective, this approach could represent a low-cost, non-invasive conservation method with real-world applications across urban and rural environments alike.

## Can Biased AI Tools Change What You Believe?

The third story tackles a question with profound societal implications: can artificial intelligence influence human beliefs? New research has investigated how biased AI-powered autocomplete tools — the kind embedded in search engines and writing assistants — can subtly shape the opinions and convictions of users over time.

The study raises important questions about transparency, accountability, and the ethical design of AI systems. As these tools become increasingly embedded in daily life, understanding their potential to nudge users toward certain viewpoints becomes critically important for both developers and consumers.

## Why These Stories Matter

Taken together, these three stories reflect the broad and deeply human concerns that modern science continues to address — our health, our environment, and our relationship with technology. Each finding, while distinct in subject, underscores the importance of curiosity-driven research and its power to shape a better-informed world.

Explore how exercise affects brain health, why hedgehogs can hear ultrasound, and how biased AI autocomplete tools may influence human beliefs.

Exercise, Hedgehog Hearing & AI Beliefs: Top Science Stories

large_4140.jpg

medium_4140.jpg

small_4140.jpg

thumbnail_4140.jpg

4140.jpg

How Exercise Boosts Brain Health, Hedgehog Ultrasound Discoveries, and AI's Influence on Human Beliefs

## Groundbreaking Trial Offers New Hope for Endometriosis Patients

A pioneering clinical trial underway in Worcestershire could fundamentally change how endometriosis is diagnosed, offering millions of women a faster, safer path to treatment without the need for invasive surgery.

Led by Worcestershire Acute NHS Trust, the study marks the first of its kind within the NHS to evaluate the effectiveness of a non-surgical diagnostic method for the condition — one that affects approximately one in ten women across the UK.

## What Is Endometriosis?

The NHS describes endometriosis as a chronic and frequently painful condition in which tissue resembling the womb lining develops outside the uterus. It most commonly affects pelvic organs, including the ovaries and fallopian tubes, and can trigger inflammation, the formation of scar tissue, and significant ongoing pain.

Despite how widespread the condition is, receiving a confirmed diagnosis has historically required surgical intervention — a process that can stretch over several years, leaving patients to endure prolonged suffering without answers.

## How the Electrode Technology Works

The trial, which launched in November, employs small electrodes placed on the surface of the abdomen to measure muscle activity within the small intestine. According to consultant gynaecologist Donna Ghosh, who is leading the research, the electrical patterns produced by intestinal activity appear to follow a distinct frequency that is uniquely associated with endometriosis patients.

### A Faster Route to Diagnosis

"What we're really focusing on is reducing the delay in diagnosis," Ghosh explained. "Patients who are suffering from symptoms suggestive of endometriosis will reach that diagnosis sooner."

Ghosh further noted that diagnostic delays in the UK have long been tied to the condition's dependence on surgical confirmation. This new non-invasive approach, she argued, could offer a far more accessible and timely alternative.

"Non-invasive tests, such as the ones we are investigating as part of this trial, will be much more helpful in diagnosing endometriosis and giving patients access to timely treatment," she said.

## A Patient's Story: 16 Years of Endometriosis

The real human cost of delayed diagnosis is powerfully illustrated by Jessica Hill, a 33-year-old woman from Tenbury Wells who has been living with endometriosis for 16 years and has undergone five separate surgeries during that time.

Hill was just 14 years old when doctors first suggested surgery as the only means of investigation. "At 14, somebody saying they were going to open you up on a hunch — that it could be this — I was terrified," she recalled. Out of fear, she delayed her first surgery by four years, spending that time in debilitating pain, often unable to attend school or college.

### The Devastating Progression of the Disease

Today, Hill lives with severe stage four endometriosis. She has undergone surgery on her bowel, bladder, pelvis, and nerves — procedures made more complex by the nature of the disease itself.

"The condition feeds off scar tissue, so the more surgery a patient undergoes, the worse it can become," Hill explained. She is a passionate advocate for earlier detection, stressing what it could mean for other women facing the same ordeal.

"If they can find it before even cutting someone open, it's going to make it quicker for them. The woman herself won't feel like she's losing her mind — because that's exactly how you feel," she said. "They can also get treatment earlier to stop it from progressing to the more serious stages."

## Join the Trial

Worcestershire Acute NHS Trust and Donna Ghosh are currently recruiting additional participants for the study. Women aged between 18 and 50 with no prior history of pelvic pain are encouraged to come forward and take part in this potentially life-changing research.

A pioneering NHS trial in Worcestershire uses electrode technology for non-invasive endometriosis diagnosis, aiming to cut years off detection times for women.

NHS Trial Uses Electrodes to Diagnose Endometriosis

fa36a270-1d5b-11f1-a5ee-870cbdcb0f98.png

Revolutionary Non-Invasive Test Could Transform Endometriosis Diagnosis

## Women Are Being Let Down by NHS Pain Management Guidelines

Women across the UK are receiving inadequate treatment for chronic back and neck pain, largely because the clinical guidelines shaping their care were designed without accounting for fundamental sex-based biological differences. That is the troubling conclusion of new research emerging from the University of Lancashire.

The study, published in the journal *Physical Therapy Reviews*, reveals that NHS guidance for the non-surgical management of chronic neck and back pain consistently uses gender-neutral language — referring only to "patients," "individuals," or "people" — effectively defaulting to a male-centric model of care. This approach systematically overlooks the distinct physiological factors that influence how women experience musculoskeletal pain.

## The Scale of the Problem

Back pain is far from a minor issue. According to the World Health Organization, lower back pain affects more than 600 million people globally. In the UK alone, the condition costs the NHS billions of pounds each year, contributes to millions of GP consultations annually, and remains one of the primary drivers of workplace absenteeism. Given this enormous burden, the quality and precision of treatment guidelines carry significant consequences.

## What the Guidelines Are Missing

The University of Lancashire review found that current clinical guidance completely disregards the influence of several female-specific biological factors, including:

- **Skeletal structure** — Women generally have a smaller, differently shaped skeleton that responds differently to physical strain
- **Hormonal fluctuations** — Hormones can directly affect pain sensitivity and musculoskeletal function
- **Pregnancy and postpartum recovery** — Carrying a child places enormous biomechanical pressure on the spine, and alignment may take months to normalise after birth
- **Menopause** — Hormonal shifts during this life stage can significantly impact bone density and joint health

Lead author Lauren Haworth, a research associate at the University of Lancashire, highlighted one particularly overlooked example. "We know that large breasts can be heavy, and without adequate support, this additional weight combined with gravity can cause strain on a woman's body, which may contribute towards neck and back pain," she explained. Yet existing guidance makes no mention of such considerations.

The guidelines also fail to account for the biological characteristics of intersex patients, representing another gap in truly inclusive care.

## Pregnancy Places Unique Demands on the Spine

Dr. Anastasia Topalidou, co-author of the study and associate professor in perinatal biomechanics and health technologies, emphasised the profound physical impact of pregnancy on spinal health. "Pregnancy places major biomechanical demands on the spine as the body adapts to the growing foetus," she noted.

Even following delivery, the spine and pelvis can require months to gradually return toward their pre-pregnancy alignment — a reality that has direct implications for how postnatal back pain should be assessed and managed.

## Real-World Consequences for Women

The practical impact of these shortcomings is significant. Matthew Parker, associate professor of neuroscience and translational psychiatry at the University of Surrey, warned of a "real risk" that female-specific factors are not being consistently factored into routine clinical assessments.

"That does not mean women are always being misdiagnosed," he clarified, "but it does mean some women may be assessed less precisely, treated less effectively, and end up in longer cycles of persistent pain and repeat appointments."

For many women, this translates into prolonged suffering, repeated healthcare visits, and a diminished quality of life — all of which might be avoided with more tailored, sex-aware clinical protocols.

## Calls for Reform

The research is calling on the UK government's women's health strategy to take decisive action by ensuring that sex-specific biological factors are transparently and consistently integrated into the development of future clinical guidelines.

Haworth stressed that acknowledging these differences is not about treating women as a special case, but about delivering genuinely personalised and equitable healthcare. "Women may still be disadvantaged simply because their biological needs differ from those of men," she said.

In response, a spokesperson for the National Institute of Health and Care Excellence (NICE) stated: "Our guidelines encourage doctors to tailor care to each person's individual needs, and we welcome research that helps us improve the guidance we provide. We will consider these findings carefully as part of our ongoing commitment to ensuring our guidance is useful, useable, and works for everyone."

## A Step Toward More Equitable Healthcare

This study adds growing momentum to the broader push for sex-disaggregated research and gender-sensitive medical guidelines. For the millions of women living with chronic back and neck pain, the message is clear: the current one-size-fits-all approach is not working, and meaningful reform is long overdue.

UK research reveals NHS back and neck pain guidelines ignore key female biological factors, leaving women undertreated and in longer cycles of chronic pain.

Women Getting Worse Back Pain Treatment, UK Study Finds

large_4497.jpg

medium_4497.jpg

small_4497.jpg

thumbnail_4497.jpg

4497.jpg

UK Study Reveals Women Are Getting Substandard Care for Back and Neck Pain

## GLP-1 Drugs Are Showing Promise Far Beyond Weight Loss

When medications like Ozempic and Wegovy first entered the mainstream conversation, the world focused almost exclusively on their remarkable ability to promote weight loss and manage type 2 diabetes. But a growing body of research now suggests these drugs may have a powerful and unexpected role to play in an entirely different health crisis — addiction.

## What a Major New Study Revealed

A large-scale study examining patients who were prescribed GLP-1 receptor agonists for diabetes management uncovered a striking pattern: these individuals were significantly less likely to receive a diagnosis of substance use disorder compared to those not taking the medication. The findings have sparked serious interest among addiction specialists, researchers, and public health experts who see this as a potential turning point in how the medical community approaches dependency treatment.

The implications are considerable. Substance use disorder affects tens of millions of people worldwide, and effective, accessible treatment options remain limited. If GLP-1 drugs can meaningfully reduce a person's vulnerability to addiction, it could represent one of the most significant developments in behavioral health in decades.

## How Might GLP-1s Affect Addiction?

### The Brain's Reward System

Researchers believe the connection between GLP-1 drugs and reduced addictive behavior may lie deep within the brain's reward circuitry. GLP-1 receptor agonists work by mimicking a naturally occurring hormone that regulates appetite and blood sugar — but these receptors are also present in regions of the brain associated with pleasure, motivation, and craving.

By modulating activity in these areas, the drugs may dampen the intense urges that drive compulsive behaviors, whether those behaviors involve food, alcohol, or other substances. Early animal studies and observational human data have both supported this theory, though scientists are careful to note that more rigorous clinical trials are still needed.

### Cravings Reduced Across the Board

Many patients taking GLP-1 medications have anecdotally reported reduced cravings not just for food, but also for alcohol and other substances. These personal accounts, while not scientific evidence on their own, have helped fuel formal investigations into the drug class as a potential addiction therapy.

## A New Chapter in Addiction Medicine?

The medical community is proceeding with cautious optimism. While the study results are encouraging, experts emphasize that correlation does not equal causation. Patients prescribed GLP-1 drugs for diabetes may differ from the general population in ways that independently lower their risk for substance use disorder. Controlled clinical trials specifically designed to test GLP-1 drugs against addiction are now underway, and their results are eagerly anticipated.

What is clear, however, is that the therapeutic potential of this drug class continues to expand in ways that few initially predicted. From managing blood sugar to reshaping body weight, and now potentially curbing addictive tendencies, GLP-1 receptor agonists are proving to be one of the most consequential pharmaceutical developments of the modern era.

## The Road Ahead

As researchers continue to investigate this promising connection, the conversation around GLP-1 drugs is evolving rapidly. If upcoming trials confirm that these medications can meaningfully reduce addiction risk or aid in recovery, it could fundamentally change treatment protocols and open access to a new class of options for millions of people struggling with substance dependence.

For now, the science remains in motion — but the early signals are difficult to ignore.

A major study suggests GLP-1 drugs like Ozempic may reduce substance use disorder risk. Could these diabetes medications transform addiction treatment?

Can GLP-1 Drugs Like Ozempic Help Treat Addiction?

large_gif

medium_gif

small_gif

thumbnail_gif

Could GLP-1 Drugs Like Ozempic Be the Next Breakthrough in Addiction Treatment?

## The Rush for Hormone Therapy Is Creating Real Supply Problems

For many women navigating menopause, hormone therapy has become a lifeline — but getting their hands on it is increasingly difficult. Following a landmark decision by the Food and Drug Administration to remove long-standing safety warnings from hormone replacement products, demand has surged dramatically, and pharmacy shelves simply aren't keeping up.

Women across the country are reporting delays, stockouts, and frustrating back-and-forth trips to the pharmacy — all in pursuit of estrogen patches that have become harder to source by the month.

## One Woman's Monthly Battle at the Pharmacy

Jennifer Skoog Mondesir knows this struggle firsthand. In her late 40s and navigating perimenopause, the New Jersey-based personal trainer depends on transdermal estrogen patches to manage her symptoms — particularly the persistent fatigue that was affecting her ability to work.

"I have to show up to my clients with energy," she explains. Before starting hormone therapy, she found herself reaching for a second or third cup of coffee just to get through the day — something entirely out of character for her.

But filling her prescription turned into its own exhausting ordeal. "I went to CVS. I can't tell you the amount of times I've been there and they're like, 'We're out of patches,'" she recalls. Each month became what she describes as a "mad scramble" to secure her medication.

Mondesir eventually switched to an online pharmacy, which resolved the disruptions. "My energy level is much better," she says, though she hopes the broader supply situation stabilizes for everyone who depends on these medications.

## Why Demand for Hormone Therapy Has Skyrocketed

The surge in demand doesn't exist in a vacuum. It's the result of a significant shift in both medical opinion and regulatory guidance over recent years.

For decades, hormone therapy carried a heavy stigma. In the early 2000s, findings from the large-scale Women's Health Initiative study prompted the FDA to place a black box warning — its most serious safety designation — on estrogen products. The study linked hormone therapy to elevated risks of heart attacks, strokes, and pulmonary embolism, causing prescriptions to plummet almost overnight.

However, evolving research and a deeper understanding of how hormone delivery methods affect outcomes gradually began to change the conversation. Last year, the FDA officially removed that black box warning, citing updated safety evidence, newer delivery mechanisms, and alternative product formulations.

"Over the past four to five years, demand has picked up as clinicians have familiarized themselves with current research and patients have become more interested," says Dr. Nora Lansen, Chief Medical Officer of Elektra Health.

## The Science Behind Transdermal Estrogen

A critical part of this story is *how* estrogen is now being delivered. The women in the original Women's Health Initiative study primarily used oral estrogen pills. Today, many patients use patches or topical gels that deliver the hormone directly through the skin — bypassing the liver entirely in a process known as transdermal delivery.

This distinction carries meaningful clinical weight. According to Dr. Lansen, transdermal estradiol carries a significantly lower risk of blood clots compared to oral formulations.

"Without passing through the liver and its metabolism, this transdermal version of estradiol is really a much safer option. And that's why there's been such demand," she explains.

This shift in delivery method has not only made hormone therapy safer for more women but has also fueled renewed confidence among both clinicians and patients — driving prescription volumes higher than manufacturers appear to have anticipated.

## Manufacturers Struggle to Keep Pace

The supply chain is clearly feeling the pressure. CVS confirmed to media outlets that multiple manufacturers have been unable to provide sufficient quantities of several estrogen products. The American Society of Health-System Pharmacists has flagged numerous estrogen-based products as experiencing current or recent shortages, though manufacturers have not publicly explained the root cause of these gaps.

Amneal Pharmaceuticals, one of the key producers of estradiol patches, acknowledged the situation directly, stating that demand increased significantly following the FDA's removal of boxed warnings. The company noted it is fulfilling existing contracts and actively working to scale up production to meet growing need.

## What This Means for Women Managing Menopause

For patients like Mondesir, the supply disruptions are more than a minor inconvenience — they represent a genuine health concern. Menopause symptoms including fatigue, mood changes, and other hormonal effects can significantly impact quality of life and daily functioning.

As the medical community continues to embrace hormone therapy as a safe and effective option for appropriate candidates, the pressure on the supply chain is unlikely to ease quickly. Women and their healthcare providers may need to explore alternative pharmacies, different formulations, or online prescription services to maintain consistent access.

The hope, shared by patients and providers alike, is that manufacturers will scale production fast enough to meet the moment — ensuring that women who need hormone therapy can actually get it.

Surging demand for hormone therapy after FDA warning removal is causing estrogen patch shortages. Learn why supply can't keep up and what patients can do.

Estrogen Patch Shortage: Why Menopause HRT Is Hard to Fill

large_jpeg

medium_jpeg

small_jpeg

thumbnail_jpeg

jpeg

Estrogen Patch Shortages Leave Menopause Patients Scrambling for Prescriptions

## The Race Against Superbugs Is Being Lost, Experts Warn

The world's ability to combat drug-resistant infections is deteriorating at an alarming pace. A new report has revealed that the pipeline of new antimicrobial drugs has contracted by 35% over the past five years, dropping from 92 medicines in development to just 60. Experts are sounding the alarm, warning that unless the pharmaceutical industry dramatically increases its investment, deaths linked to drug-resistant infections could double to 8 million annually by 2050.

The findings come from the Access to Medicine Foundation (AMF), a Netherlands-based nonprofit supported by the Wellcome Trust, which assessed the antimicrobial research efforts of 25 companies worldwide.

## A Dangerously Thin Development Pipeline

"Overall, the research and development pipeline remains worryingly thin, and industry investment has lost momentum," said Jayasree K Iyer, the AMF's chief executive. She went further, describing antimicrobial resistance as the single greatest threat facing global healthcare today.

Particularly concerning is the near-absence of medicines being developed for young children. Only five drugs are currently in development for children under the age of five — a demographic that is disproportionately vulnerable to life-threatening infections.

The Fleming Initiative, named after Scottish physician Alexander Fleming who famously discovered penicillin in London nearly a century ago, has projected an even grimmer outcome, estimating that drug-resistant infections could claim up to 10 million lives annually by 2050.

## Big Pharma Steps Back from Antibiotic Research

Cancer surgeon and NHS investigator Lord Ara Darzi, who serves as executive chair of the Fleming Initiative, underscored the moral dimension of the crisis. He noted that infection is the second-leading cause of death among cancer patients, stating that pharmaceutical companies carry a "moral responsibility in underwriting the risk" of antimicrobial research.

"New therapies mean cancer can be fought, but then sadly patients succumb to an infection that was treatable a decade ago," Lord Darzi said at the AMF report launch. Drawing on a sports analogy, he added: "You don't win a game if you have three good strikers and your defence is weak."

Of the large pharmaceutical companies still active in this space, the UK's GSK leads the field with 30 active antimicrobial projects. It is joined by Japan's Shionogi and Otsuka as the only major players continuing to invest meaningfully in this area. Notably, US giant Pfizer, which shared the top position with GSK in 2021, has significantly scaled back its efforts.

Britain's largest pharmaceutical company, AstraZeneca, does not feature in the rankings at all, as infectious disease research has never been a core focus of its business and it currently holds no antibiotic portfolio.

## Resistance Is Outpacing Research

Claudia Martínez, AMF's director of research, was blunt in her assessment: "We don't have enough research going into antimicrobials to outpace resistance."

Data from the World Health Organization paints a stark picture of just how rapidly the situation is worsening. In 2023, one in six laboratory-confirmed bacterial infections showed resistance to antibiotic treatments. More troublingly, over 40% of antibiotics lost effectiveness against common blood, gut, urinary tract, and sexually transmitted infections between 2018 and 2023.

Hospitals around the world have reported a sharp rise in previously manageable infections that no longer respond to standard treatments.

## Low-Income Countries Bear the Heaviest Burden

People living in low- and middle-income countries, where infectious diseases already cause the most harm, face the greatest risk from drug-resistant superbugs. The AMF report emphasizes the urgency of action, with Iyer stating plainly: "There is no time to lose."

Beyond drug development, experts stress that curbing the overuse of antibiotics — particularly in food production — and managing antibiotic waste responsibly are equally critical steps in slowing the spread of resistance.

## Rethinking the Economics of Antibiotic Development

A fundamental challenge in addressing this crisis is economic. The market for new antibiotics is simply not profitable enough to attract widespread pharmaceutical investment. John-Arne Røttingen, chief executive of the Wellcome Trust, acknowledged that the shortage of effective antibiotics represents a "big challenge for society."

To address the financial disincentive, the European Commission is exploring the introduction of transferable exclusivity vouchers, which would grant developers of new antimicrobial drugs an additional 12 months of data protection — effectively extending their period of market exclusivity.

Røttingen also advocated for the wider adoption of the NHS's subscription-based model for antibiotics, which provides pharmaceutical companies with a guaranteed revenue stream regardless of sales volume. He argued that other high-income nations should implement similar systems to make antimicrobial development a more viable commercial pursuit.

### A Window of Opportunity

Despite the bleak outlook, AMF's Iyer pointed to three recently approved antibiotics and seven additional promising medicines currently in late-stage development as evidence that progress is achievable. "It is possible to tilt the battle against superbugs in humanity's favour," she said — but only if the pharmaceutical industry, governments, and international bodies act with far greater urgency than they have so far.

Experts warn the global pipeline for new antibiotics has shrunk by 35% in five years, with drug-resistant infections projected to kill 8 million annually by 205

Superbug Drug Pipeline Shrinks 35% as Deaths Set to Double

large_2553.jpg

medium_2553.jpg

small_2553.jpg

thumbnail_2553.jpg

2553.jpg

Global Superbug Pipeline Shrinks by 35% as Death Toll Projected to Double by 2050

## Daily Multivitamin May Slow Biological Aging, New Research Finds

Research published in the journal *Nature Medicine* indicates that taking a daily multivitamin for two years may modestly slow certain biological aging markers — though scientists caution that the practical health implications remain uncertain.

## Biological Age vs. Chronological Age

Unlike chronological age, which simply counts how many years a person has been alive, biological age reflects the actual condition and functioning of the body. Scientists often estimate biological age by examining DNA methylation — changes to DNA that accumulate over time and influence how genes are expressed. One prevailing theory holds that slowing these biological aging markers could help delay or reduce the severity of age-related diseases, potentially extending the number of healthy years a person enjoys.

## What the Study Found

The US-based study — which received partial funding from confectionery giant Mars — enrolled 958 healthy adults with an average age of approximately 70 years. Participants were divided into four groups and assigned to take either a daily cocoa extract combined with a multivitamin, cocoa extract with a placebo, a multivitamin with a cocoa extract placebo, or two placebos.

Blood samples were collected at the beginning of the trial and again at the one- and two-year marks. Researchers analyzed these samples for changes across five distinct DNA methylation measures, commonly referred to as "epigenetic clocks."

After adjusting for variables such as age, sex, and baseline readings, the team found that participants taking a daily multivitamin demonstrated a slowdown in biological aging across two of the five epigenetic clocks — particularly those associated with estimating mortality risk. In total, the researchers estimated this amounted to roughly four months less biological aging over the two-year period.

### Who Benefited Most?

Interestingly, the effects appeared more pronounced in individuals who were aging at a faster biological rate at the outset of the study. Researchers suggested this may be because those participants had greater nutritional deficiencies to begin with.

"Nutritional status may partly explain the results, but these epigenetic clocks may reflect other age-related risk factors," said Dr. Howard Sesso, an epidemiologist at Mass General Brigham and senior author of the study.

The cocoa extract supplement, by comparison, showed no significant effect on any of the five epigenetic clocks and did not appear to interact with the multivitamin in any meaningful way.

## Experts Urge Caution

Despite the findings, Sesso was careful not to overstate their significance. "There are no known risks for taking a multivitamin in our two large clinical trials. At the same time, we do not know for sure who benefits, and how," he noted, adding that the results should not be interpreted as a recommendation for all older adults to begin taking multivitamins.

Experts not involved in the study echoed that measured approach. Dr. Marco Di Antonio, a biological aging specialist at Imperial College London, pointed out that the connection between epigenetic clocks and tangible aging outcomes remains poorly understood.

"I do not think that people should start taking multivitamins daily necessarily, but these results demonstrate that having a healthy diet and lifestyle will have an effect on your biological age," Di Antonio said. He further warned that multivitamins would be "pointless" without an accompanying healthy lifestyle, as poor habits can negatively impact aging in ways that supplements cannot reverse.

Noteworthy too is a large study published last year that found daily multivitamin use did not extend lifespan and may even be associated with a slightly elevated risk of early death — findings that stand in contrast to the current research.

### A Word From Independent Experts

Dr. Pilar Guallar Castillón, an associate professor at the Autonomous University of Madrid, offered a more direct perspective. She highlighted that the clinical trial associated with this study found no measurable effect of multivitamin use on the primary causes of death and illness.

"My personal advice is to stop taking multivitamins, whether in pill or gummy form," she stated. "Eat a healthy, varied diet rich in fruit and vegetables — the main natural source of vitamins and minerals — and do not waste your money on nutritional supplements. There are huge commercial interests in their consumption and a lack of clinical evidence."

Colleagues from Columbia University's Mailman School of Public Health similarly stressed that the effects observed in the study were very small and that further research is needed to determine whether these findings translate into genuine, clinically meaningful health benefits.

## The Bottom Line

While the idea that a simple daily supplement could slow the hands of biological time is compelling, the science remains far from settled. The modest effects observed in this study, combined with conflicting evidence from other research, suggest that no multivitamin can substitute for a balanced diet, regular physical activity, and a healthy overall lifestyle. For now, experts agree: eat well, live well, and consult your doctor before adding any supplement to your routine.

New research suggests daily multivitamins may modestly slow biological aging markers, but experts say healthy lifestyle choices matter far more than supplements

Can a Daily Multivitamin Slow Biological Aging?

large_4434.jpg

medium_4434.jpg

small_4434.jpg

thumbnail_4434.jpg

4434.jpg

Daily Multivitamin May Slow Biological Aging, New Research Finds

## UK Cancer Death Rates Have Fallen by Almost a Third Since the 1980s

A landmark analysis has revealed that the rate of cancer-related deaths across the United Kingdom has declined by nearly 30% since the late 1980s, marking one of the most significant public health achievements in modern British history. The findings, published by Cancer Research UK (CRUK), highlight decades of progress in cancer prevention, early detection, and treatment innovation.

At its peak in 1989, approximately 355 out of every 100,000 people in the UK died from cancer annually. Today, that figure stands at around 247 per 100,000 — a 29% reduction that reflects transformative changes across the entire cancer care landscape.

## Significant Declines Across Multiple Cancer Types

The progress becomes even more striking when examining the past decade alone, during which overall cancer mortality dropped by 11%. Several specific cancer types have seen particularly dramatic improvements:

- **Stomach cancer**: death rate fell by 34%
- **Ovarian cancer**: down 19% between 2012–2014 and 2022–2024
- **Lung cancer**: reduced by 22%
- **Oesophageal cancer**: dropped 12%
- **Breast cancer**: fell 14%
- **Cervical cancer**: declined 11%
- **Bowel cancer**: dipped 6%
- **Leukaemia**: decreased 9%

Cervical cancer deserves special mention — its death rate has plummeted by 75% since the 1970s, largely attributed to the NHS cervical screening programme and, more recently, the widespread rollout of the human papillomavirus (HPV) vaccine. Since its introduction in 2008, approximately 6.5 million people in the UK have received the HPV vaccine, and its impact on reducing cervical cancer cases continues to grow.

## Some Cancer Rates Are Moving in the Wrong Direction

Despite the overall positive trend, certain cancers have seen their mortality rates rise over the past decade. Gallbladder cancer increased by 29%, eye cancer climbed 26%, liver cancer rose 14%, and kidney cancer edged up 5%. Death rates for thyroid cancer, pancreatic cancer, and melanoma remained broadly stable during the same period.

These figures serve as a reminder that progress, while substantial, is far from uniform across all cancer types.

## What Is Behind the Improvements?

CRUK attributes the falling death rates to a combination of interconnected factors. Public health measures such as smoking bans have played a critical role in reducing cancer incidence. Nationwide screening programmes for breast, bowel, and cervical cancers have enabled earlier detection, when treatment is far more likely to be successful.

Advances in medical science have also been pivotal. Abiraterone, a drug that inhibits testosterone from fuelling prostate cancer growth, was developed by CRUK scientists and has contributed to an 11% reduction in prostate cancer mortality over the past decade. More targeted therapies and less invasive treatment approaches have improved outcomes while reducing the burden on patients.

Dr Sam Godfrey, Science Engagement Lead at CRUK, described the significance of the findings: "These figures represent decades of crucial scientific breakthroughs — from vaccines that prevent cancer to kinder, more targeted treatments. Because of this, thousands more people today can make memories, reach milestones, and spend precious time with their loved ones."

## Challenges That Still Lie Ahead

While the data paints an encouraging picture, serious challenges remain. Cancer continues to be the leading cause of death in Britain, accounting for roughly one in four fatalities. The UK's cancer survival rates still trail behind several European nations, including Romania and Poland — a gap that experts say must be urgently addressed.

Furthermore, an expanding and ageing population means that more people are being diagnosed with cancer than ever before — at a rate of one new diagnosis every 75 seconds in the UK. Despite falling death rates per 100,000 people, the absolute number of cancer deaths continues to rise.

### The NHS Cancer Crisis

The healthcare system's ability to deliver timely cancer care has come under intense scrutiny. A Guardian investigation found that three-quarters of NHS hospital trusts are failing to meet cancer care standards, leading medical experts to declare a national emergency. Critically, no cancer waiting time targets have been met by the NHS since 2015.

Adding to the pressure, Britain's departure from the European Union has complicated access to life-saving treatments. According to one of the most comprehensive reports on the subject, Brexit has "damaged the practical ability" of doctors to enrol NHS patients in international clinical trials, cutting off access to revolutionary therapies and slowing research.

### Government Response and Future Investment

In response to the mounting crisis, the government recently announced a £2 billion investment aimed at overhauling cancer services across England. The pledge promises faster diagnoses, shorter treatment waiting times, and enhanced support for patients living with cancer. Under the new national cancer plan, all three key waiting time standards are targeted to be met by 2029.

Dr Godfrey also stressed the importance of maintaining research momentum: "It's essential that the government makes it easier and faster to set up clinical trials, as well as providing NHS staff with the time and space to carry out life-saving research."

## A Cause for Optimism — With Caution

The near-30% reduction in cancer death rates since the 1980s is a testament to what sustained investment in science, public health, and medical innovation can achieve. Yet the work is far from finished. Closing the gap with leading European nations, addressing rising rates in certain cancer types, and ensuring every patient has timely access to the best available treatments remain urgent priorities for both the NHS and policymakers alike.

Cancer death rates in the UK have dropped by almost a third since 1989. Discover what's driving the progress and the challenges that still remain.

UK Cancer Death Rates Fall Nearly 30% Since the 1980s

large_4160.jpg

medium_4160.jpg

small_4160.jpg

thumbnail_4160.jpg

4160.jpg

UK Cancer Mortality Drops Nearly 30% Since the 1980s — Here's What's Driving the Progress

## Too Wired to Wind Down? Proven Bedtime Rituals to Calm Your Body and Mind

After a long, hectic day, quieting your thoughts and drifting off to sleep can feel nearly impossible. The mental noise from deadlines, responsibilities, and unresolved worries has a way of following you straight into the bedroom. The good news? A consistent wind-down routine can signal to your body that it is time to rest — and sleep specialists have the science to back it up.

## Why a Bedtime Routine Actually Works

A thoughtfully designed evening routine does more than just help you feel relaxed — it triggers a chain of biological responses that prepare your body for sleep. When you consistently engage in calming pre-sleep habits, your brain begins to associate those activities with rest. Whether it is a quiet hobby like reading or knitting, a mindfulness practice like meditation, or simply adjusting the atmosphere in your home, these rituals communicate one clear message to your nervous system: the day is over, and it is safe to let go.

## Strategy 1: Dim the Lights Early

One of the simplest and most effective changes you can make is controlling your lighting in the evening. Exposure to bright light suppresses melatonin — the hormone responsible for regulating your sleep-wake cycle. By dimming your environment, you encourage your body to produce melatonin naturally and ease into a sleepy state.

### Try This Tonight

Switch off harsh overhead lights in your living room and bedroom as the evening progresses. Replace them with dimmable lamps or bulbs with a lower wattage. When you are ready for bed, turn off all lamps completely. Keep in mind that even small amounts of light can interrupt your sleep — even through closed eyelids. If blackout curtains are not an option, an eye mask is a worthwhile investment.

## Strategy 2: Lower Your Body Temperature

According to Dr. Seema Khosla, a sleep medicine physician and host of the *Talking Sleep* podcast, the speed at which your body temperature drops directly influences how quickly you fall asleep. A cooler core temperature is a biological cue that tells your brain it is time to shut down for the night.

### Try This Tonight

Take a warm shower or bath before bed. The contrast between stepping out of a warm shower and into a cool room encourages a rapid drop in body temperature, which accelerates the onset of sleep. Set your thermostat to around 68 degrees Fahrenheit for an ideal sleep environment. A cooler room may make a surprising difference in both how fast you fall asleep and the quality of rest you get.

## Strategy 3: Protect Your Emotional State Before Bed

Anything that triggers strong emotions — whether excitement, anxiety, or stress — can keep your nervous system on high alert and make sleep difficult. Sleep researchers emphasize the importance of cultivating a sense of safety and calm as bedtime approaches.

### Try This Tonight

Take an honest look at your current evening habits. Are you scrolling through work emails, getting caught up in stimulating conversations, or planning exciting events right before bed? These activities may seem harmless but can elevate your emotional arousal at the worst possible time. Instead, opt for small, meaningful moments of connection — a hug with a loved one, a few minutes of gentle conversation, or a brief gratitude practice. These simple acts can foster a sense of well-being that eases you into sleep.

## Strategy 4: Empty Your Mind Onto Paper

A racing mind filled with tomorrow's to-do list or unresolved worries is one of the most common barriers to falling asleep. Rather than lying in the dark hoping those thoughts will disappear, sleep experts recommend addressing them proactively — before the lights go out.

### Try This Tonight

Keep a notebook on your nightstand. Before bed, write down every concern, task, or lingering thought that is occupying mental space. Next to each one, jot down a single, concrete action step you plan to take the following day. The key here is not to solve the problem — attempting to do so can actually increase mental arousal and keep you awake even longer. Simply acknowledging each stressor and assigning it a next step is enough to signal to your brain that it has been handled and can be set aside until morning.

## Build Your Routine One Step at a Time

You do not need to overhaul your entire evening schedule overnight. Start by incorporating one or two of these strategies and build from there. The goal is to create a consistent, calming pre-sleep ritual that your body and mind begin to recognize as the bridge between the busyness of the day and the deep rest you need each night. Over time, these habits can transform not just how quickly you fall asleep, but the overall quality of your rest.

Struggling to fall asleep? Discover expert-backed bedtime rituals that calm your mind, lower stress, and prepare your body for deep, restful sleep.

Bedtime Rituals to Calm Your Body and Mind for Sleep

Too Wired to Wind Down? Proven Bedtime Rituals to Calm Your Body and Mind

## The Clock Changes. Most People Complain. I Celebrate.

Every spring, like clockwork, the grumbling begins. Social media floods with memes about stolen sleep. Politicians draft bills to eliminate the time change. Health professionals warn of disrupted circadian rhythms. The national mood turns sour over a single lost hour.

And then there's me — apparently the one person in America who genuinely looks forward to it.

I'm not being contrarian for the sake of it. After two decades serving in the U.S. Navy, operating in high-pressure environments where conditions shifted without warning and hesitation could cost lives, I developed a fundamentally different relationship with disruption. Daylight saving time, to me, isn't a nuisance. It's an opportunity — one that most people are too frustrated to recognize.

## Reframing the Disruption: A Built-In Annual Stress Test

In the military, we had a simple philosophy: you don't wait for ideal conditions. You adapt, execute, and move forward. Perfect circumstances are a fantasy. What matters is how quickly and effectively you respond when circumstances shift.

Daylight saving time operates on that same principle. I call it **tactical discomfort** — a low-stakes, nationally synchronized exercise in psychological flexibility. Losing one hour of sleep is not a catastrophe. It's a controlled challenge. If a 60-minute shift throws your entire week into chaos, the clock isn't your problem. Fragility is.

We talk constantly about building resilience. Here, twice a year, is a practical chance to actually practice it.

## The Pattern Interrupt You Didn't Know You Needed

Most of us are running on autopilot. Same alarm. Same commute. Same habits. Same excuses recycled week after week. Comfort is the enemy of growth, and routine is comfort's most loyal accomplice.

The time change is a forced pattern interrupt. It jolts us out of our automated rhythms and demands a manual override of our mornings, our schedules, and our sleep. Rather than resenting that jolt, consider using it deliberately.

There are 168 hours in every week. The spring clock shift is the one moment each year when the entire country is simultaneously prompted to reconsider how those hours are being spent. Think of it as a blank slate:

- **Audit your morning routine** and identify what's working
- **Eliminate a habit** that's been quietly draining your energy
- **Add a workout** you've been putting off since January
- **Reclaim time** lost to mindless scrolling or passive consumption

Growth rarely emerges from comfort zones. Disruption, even minor disruption, creates the opening.

## A Symbolic Shift That Carries Real Psychological Weight

Beyond the practical, there's a deeper psychological dimension worth considering. The spring time change is a symbolic threshold — a marker that separates the inward contraction of winter from the expansive energy of longer, brighter evenings.

Humans are deeply wired to respond to seasonal signals. Even an artificially manufactured shift in the clock can function as a meaningful mental pivot point. It becomes permission — permission to change direction, recalibrate priorities, and step into a more intentional, higher-output version of yourself.

We don't require perfect conditions to reset. We need a trigger. Daylight saving time is one of the most reliable triggers we have.

## One of the Last True National Shared Experiences

In an era of deep cultural division, the time change remains one of the few experiences that still touches nearly all of us at once. Regardless of political affiliation, geography, or background, most of the country moves the clock together and feels the same collective shift in rhythm simultaneously.

Time is not purely biological — it's social. It's a shared agreement. And twice a year, the majority of Americans participate in that agreement in near-unison, around something entirely apolitical. That shared experience shouldn't be dismissed lightly. In a fragmented culture, it functions as connective tissue.

## The Practical Benefit Hidden in Plain Sight

There's also a straightforward safety argument that rarely gets the attention it deserves. For decades, the biannual clock change has served as a reliable reminder for households to check smoke detector batteries and refresh emergency preparedness kits.

Without that built-in, recurring nudge, countless families would simply forget. What feels like an inconvenience quietly doubles as a life-saving prompt — a small but meaningful public safety ritual embedded into the calendar.

## Stop Being a Victim of the Clock

Here's the honest truth: the time change doesn't make you tired. Your habits do. It doesn't steal your hour. It exposes how carelessly you were already spending the other 167.

In the military, blaming external conditions isn't an option. You master your schedule regardless of the sun, the season, or the circumstances. Civilian life, however, tends to treat time as something that simply *happens* to us — something we endure rather than command.

Daylight saving time invites a different mindset entirely:

- **Adapt faster** than you did last year
- **Reset deliberately** instead of drifting back into old patterns
- **Leverage disruption** as a catalyst rather than a complaint

## The Real Question Isn't Whether to Keep It

You can spend the next week complaining about a lost hour, posting memes, and blaming the government for your fatigue. Or you can treat it for what it actually is: a stress test, a reset button, a national synchronization event, and a psychological pivot point — all rolled into one Sunday morning.

Maybe the debate shouldn't be whether we abolish daylight saving time. Maybe the real question is whether we're disciplined enough — and self-aware enough — to use it.

While most Americans dread the time change, one Navy veteran argues daylight saving time is a powerful reset tool for resilience, productivity, and growth.

#fitness